Boston Scientific logo

Boston Scientific Income Statement

Revenue, expenses, and profitability over time

Boston Scientific generated $20.6B in trailing twelve-month revenue, up 0.2% year-over-year. Net income was $3.6B with a 17.26% net margin. Gross margin stands at 69.16% and operating margin at 18.4%. Diluted EPS is $2.39, which grew 0.7% year-over-year. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-05-01
Market Cap$85.9B
P/E Ratio24.13
ROE14.81%

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$23.0M$133.0M$146.0M$183.0M$30.0M-$176.0M

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$4.6B$4.7B$5.1B$5.1B$5.3B$5.2B